Home › Funds › SIGNATURE ESTATE & INVESTMENT ADVISORS LLC › ABBV

SIGNATURE ESTATE & INVESTMENT ADVISORS LLC position in ABBV

ABBVIE INC · Health Care

SIGNATURE ESTATE & INVESTMENT ADVISORS LLC reported holding 156,714 shares of ABBV (ABBVIE INC) in its Q3 2026 13F filing — a position valued at US$41.0M, representing 0.72% of its reported portfolio and ranking #30 among its reported holdings. SIGNATURE ESTATE & INVESTMENT ADVISORS LLC has disclosed ABBV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)156.71K sh
Reported value held$40.99M
Portfolio Weight0.72%
First reportedQ3 2023
Last changeAdd
Updated2026-10-15

Last updated: 2026-10-15 · Source: SEC EDGAR Form 13F-HR

How SIGNATURE ESTATE & INVESTMENT ADVISORS LLC's ABBV position evolved

SIGNATURE ESTATE & INVESTMENT ADVISORS LLC first disclosed a stake in ABBV in Q3 2023 at 1,713 shares (US$256K). The position peaked in Q3 2026 at 156,714 shares, worth US$41.0M. Across 13 filings, SIGNATURE ESTATE & INVESTMENT ADVISORS LLC increased the stake 7 time(s), trimmed it 5 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 156,714 shares valued at US$41.0M — an increase of 151,402 shares quarter over quarter.. Notable position changes include a 246% increase in Q2 2024 (shares rose 16% over the following quarter), a 2850% increase in Q3 2026 (shares rose 9% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 1.71K $256.00K New
Q4 2023 1.59K $246.00K Reduce
Q1 2024 1.74K $316.62K Add
Q2 2024 6.02K $1.03M Add
Q3 2024 6.06K $1.20M Add
Q4 2024 6.21K $1.10M Add
Q1 2025 6.53K $1.37M Add
Q2 2025 5.87K $1.09M Reduce
Q3 2025 5.62K $1.30M Reduce
Q4 2025 5.40K $1.23M Reduce
Q1 2026 5.49K $1.19M Add
Q2 2026 5.31K $1.34M Reduce
Q3 2026 156.71K $40.99M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABBV and 13F data

ABBV (ABBVIE INC) is a Health Care company. 35 other funds we track also report a position in ABBV — the largest reported positions include Vanguard Group (US$41.31B), BlackRock Inc (US$37.62B), VANGUARD CAPITAL MANAGEMENT LLC (US$29.04B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABBV

All ABBV fund holders →

FAQ

How long has SIGNATURE ESTATE & INVESTMENT ADVISORS LLC held ABBV?

SIGNATURE ESTATE & INVESTMENT ADVISORS LLC has disclosed ABBV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is SIGNATURE ESTATE & INVESTMENT ADVISORS LLC's current position in ABBV?

As of Q3 2026, SIGNATURE ESTATE & INVESTMENT ADVISORS LLC holds 156.71K shares of ABBV (ABBVIE INC), valued at $40.99M, representing 0.72% of its reported portfolio and ranking #30.

Has SIGNATURE ESTATE & INVESTMENT ADVISORS LLC been buying or selling ABBV?

In the latest 13F filing (Q3 2026), SIGNATURE ESTATE & INVESTMENT ADVISORS LLC increased its position in ABBV. The position peaked in Q3 2026 at 156.71K shares.

Which other funds hold ABBV?

Other major institutional holders of ABBV include Vanguard Group, BlackRock Inc, VANGUARD CAPITAL MANAGEMENT LLC, among 35 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.